Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Benzilates”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 325 records · Page 18Linked to original sources

Evidence of paired M2 muscarinic receptors.

Binding assays involving various antagonists, including N-[3H] methylscopolamine, [3H]quinuclidinyl benzilate, AFDX-116, pirenzepine, and propylbenzilylcholine mustard, disclosed only a single population of M2 muscarinic receptors in membranes from the rat "brainstem" (medulla, pons, and colliculi). However, competition curves between N-[3H]methylscopolamine and various agonists, including oxotremorine, cis-dioxolane, and acetylethylcholine mustard, showed approximately equal numbers of guanine nucleotide-sensitive high affinity (H) sites and guanine nucleotide-insensitive low affinity (L) sites. This 50% H phenomenon persisted in different buffers, at different temperatures, after the number of receptors was halved (and, thus, the remaining receptor to guanine nucleotide-binding protein ratio was doubled), after membrane solubilization with digitonin, and when rabbit cardiac membranes were used instead of rat brainstem membranes. Preferential occupation of H sites with acetylethylcholine mustard, and of L sites with quinuclidinyl benzilate or either mustard, yielded residual free receptor populations showing predominantly L and H sites, respectively. Low concentrations of [3H]-oxotremorine-M labeled only H sites, and the Bmax for these sites was 49% of the Bmax found with [3H]quinuclidinyl benzilate plus guanine nucleotide. These and other results are most consistent with the idea that H and L receptor sites exist on separate but dimeric receptor molecules and with the hypothesis that only the H receptors cycle between high and low affinity, depending upon interactions between this receptor molecule and a guanine nucleotide-binding protein.

Animals↗

Quantitative autoradiography of major neurotransmitter receptors in the monkey striate and extrastriate cortex.

In vitro autoradiography was used to determine the binding properties and distribution of 9 major neurotransmitter receptors and their subtypes in the striate (area 17 of Brodmann) and extrastriate (areas 18 and 19) cortex of 1 infant and 3 adult rhesus monkeys. Differences in total labeling and nonspecific labeling, as well as Kd and Bmax values, were determined for all cortical layers and sublayers in both cytoarchitectonic areas by Scatchard analysis of autoradiograms. Area 17 differed from area 18 in the laminar pattern and density of virtually every ligand examined, i.e., 3H-clonidine, 3H-prazosin, 125I-iodopindolol, 3H-quinuclidinyl benzilate, 3H-5-hydroxytryptamine, 3H-ketanserin, 3H-muscimol, 3H-flunitrazepam, and 3H-spiperone. Kd and Bmax values for each ligand were remarkably consistent across the 3 adult monkeys analyzed quantitatively. Particularly dramatic contrasts were observed with clonidine, 5-hydroxytryptamine, and ketanserin, which have high affinity for alpha 2-adrenergic, 5-HT1-, and 5-HT2-receptors, respectively. The differences in distribution of these ligands, especially clonidine and 5-hydroxytryptamine, correlated well with specific laminae and hence exhibited distinctly different patterns in areas 17 and 18. Other ligands, such as flunitrazepam and quinuclidinyl benzilate that bind to GABAergic and cholinergic receptors, were visually less discriminating both among layers and between regions. However, layer for layer, the Bmax values for quinuclidinyl benzilate were higher in area 17 than 18, indicating the subtle differences between areas may be revealed only by quantitative measures. Some ligands were particularly dense in layer I (iodopindolol in areas 17 and 18; 5-hydroxytryptamine in area 18), and others subdivided cortical layers that are otherwise cytoarchitectonically uniform (e.g., flunitrazepam and clonidine in layer VI of area 17), indicating that areal differences in ligand binding are not a simple read-out of cell-packing density but most likely reflect a genuine difference related to the neurotransmitters of intrinsic and extrinsic afferents in each area. The presence of binding sites in every layer of both areas for all ligands examined indicates that their distribution across laminae is quantitative and not all-or-none. No layer contained less than 50% of binding sites present in any other layer. These findings reveal that visual cortical areas differ in density and lamination of neurotransmitter receptors and presumably in their sensitivity to circulating levels of endogenous neurotransmitters and pharmacologically active compounds.

Animals↗

Characterization of muscarinic cholinergic receptor subtypes in human peripheral lung.

The authors have characterized the muscarinic cholinergic receptor subtypes in human peripheral lung membranes using the selective muscarinic antagonist [3H]pirenzepine [( 3H]PZ) and the classical muscarinic antagonist [3H](-)-quinuclidinyl benzilate. High-affinity binding with pharmacologic specificity was demonstrated for both radioligands. The high affinity Kd for [3H]PZ binding determined from saturation isotherms was 5.6 nM, and the Kd for [3H](-)-quinuclidinyl benzilate binding was 14.3 pM. Approximately 62% of the total muscarinic binding sites in human peripheral lung bind [3H]PZ with high affinity. There was no significant effect of the guanine nucleotide, guanyl-5'-yl imidodiphosphate, on the inhibition of [3H](-)-quinyclidinyl benzilate binding by the muscarinic agonist carbachol in peripheral lung membranes. If the muscarinic receptor with high affinity for PZ has an important role in bronchoconstriction, its characterization could result in the development of more selective bronchodilators.

Adult↗

[The biotransformation of propiverin hydrochloride (Mictonorm)].

Propiverine hydrochloride [1; hydrochloride of O-n-Propyl-(N-methylpiperidinyl-4)-benzilate; Mictonorm] is metabolized after p.o. application of 25 mg/kg on rats almost completely. Besides of small amounts of unchanged 1 in urine were detected the phase-I metabolites N-methylpiperidinyl(4)-benzilate (2), 2,2-diphenyl-5-methyl-1, 4-dioxan-3-on (3), N-oxide of 2 (4), benzilic acid (5) and O-n-propylbenzilic acid (6) using ms, dc and hplc comparison of the isolated compounds with authentic samples. The structure of further metabolites, i.e. monohydroxy-benzophenone (7), acetoxy-1-derivatives (8) and ethylbenzilate (9) were elucidated by high resolution MS.

Animals↗

Species difference in the muscarinic receptors of thoracic aorta.

Muscarinic receptors in rabbit aortic membranes were characterized by binding assays using I-[3H]quinuclidinyl benzilate, and compared with muscarinic receptors in dog and bovine aortas. In the rabbit aortic membranes, I-[3H]quinuclidinyl benzilate specifically bound with high affinity (KD = 28.1 pM) to a single class of sites (maximum number of binding sites = 57.2 fmol/mg of protein) which have characteristics of muscarinic receptors. Drug competition curves indicated a single class of binding sites for antagonists (e.g., K1 = 160 nM for pirenzepine), but suggested the presence of two affinity binding sites (or states) for agonists (e.g., K1 = 8.29 nM and K2 = 0.32 microM for oxotremorine, respectively). I-[3H]quinuclidinyl benzilate also bound to a single class of sites in the membranes of dog and bovine aortas, with similar affinities to the case of rabbit aorta. But the maximum number of binding site values were significantly lower than the value in the rabbit aorta. Furthermore, bovine aorta exhibited a higher affinity (K1 = 8.7-22.3 nM) for pirenzepine, but a lower affinity (K1 = 0.62-1.46 microM) for oxotremorine, as compared with rabbit and dog aortas. Accordingly, muscarinic receptors in the aorta are different between animal species, regarding its density and interactions with muscarinic agents. The receptors in bovine aorta may be M1-subtype but receptors in rabbit and dog aortas may be relatively M2-subtypes.

Animals↗

Methacholine-induced decrease in the cholinergic muscarinic receptor content in the perfused working rat heart.

The regulation of the muscarinic receptor by the agonist methacholine was investigated in the perfused working rat heart. After 2.5 hr of perfusion with 4 microM methacholine, the number of (-)-[3H]-quinuclidinyl benzilate binding sites was significantly reduced (10-18%) in the right and left atria and left ventricle when compared with controls (2.5 hr of perfusion in the absence of methacholine). Scatchard analysis revealed that there was no change in the apparent dissociation constant for quinuclidinyl benzilate. Furthermore, when hearts were perfused for 2.5 hr with methacholine in the presence of (-)-scopolamine, a muscarinic receptor antagonist, no significant loss of receptor was observed. After perfusing with methacholine for 2.5 hr followed by 2.5 hr in the absence of agonist, the number of quinuclidinyl benzilate binding sites returned to control levels. These results suggest that agonist-induced receptor decreases or down regulation requires receptor activation and not just simple receptor occupancy. This decrease, moreover, is reversible. The perfused working rat heart represents a physiological system in which the mechanisms of muscarinic receptor regulation can be studied.

Animals↗

Topographical distribution of decrements and recovery in muscarinic receptors from rat brains repeatedly exposed to sublethal doses of soman.

[3H]Quinuclidinyl benzilate binding to rat brain muscarinic receptors decreased after repeated exposure to soman, a potent organophosphorus cholinesterase inhibitor. The topographical distribution of this decrement was analyzed by quantitative receptor autoradiography. After 4 weeks of soman, three times a week, quinuclidinyl benzilate binding decreased to 67 to 80% of control in frontal and parietal cortex, caudate-putamen, lateral septum, hippocampal body, dentate gyrus, superior colliculus, nucleus of the fifth nerve, and central grey. Minor or no decreases were observed in thalamic or hypothalamic nuclei, reticular formation, pontine nuclei, inferior colliculus, nucleus of the seventh nerve, and cerebellum. Scatchard analyses of saturation curves using frontal cortex sections from soman-treated rats revealed a decrease in maximal quinuclidinyl benzilate binding from that in control rats and a return toward control levels by 24 days without any significant change in affinity. These brain areas showing significant decrements in muscarinic receptors recovered with a similar time course. An estimate of the time for 50% recovery for some of the brain areas was 14 days for superior colliculus, 16 days for cortex, and 19 days for hippocampal body. The application of quantitative receptor autoradiography to analyze receptor alterations has been valuable in localizing the telencephalon as a region more susceptible to change in receptor concentration.

Animals↗

Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.

Muscarinic receptors, [14C]choline uptake and acetylcholinesterase (AChE) activity in central and peripheral tissues of guinea-pigs treated repeatedly with diisopropylfluorophosphate (DFP) were simultaneously determined. After repeated DFP (1 mg/kg) administration, there was a significant decrease in specific [3H] quinuclidinyl benzilate binding only in the striatum, ileal longitudinal muscle and urinary bladder among various tissues examined. Scatchard analysis revealed that the administration of DFP at 0.5, 1 and 2 mg/kg which depressed the tissue AChE by 50 to 90%, caused a dose-dependent decrease (20-50%) in striatal and ileal [3H]quinuclidinyl benzilate binding sites without a change in the dissociation constant. The lower dose (0.2 mg/kg) of DFP depressed significantly the AChE in both tissues by 30% but failed to alter their [3H]quinuclidinyl benzilate binding sites. High affinity uptake of [14C]choline in the striatum and ileal longitudinal muscle was significantly decreased by repeated administration of DFP at 0.5 and 1 mg/kg but not 0.2 mg/kg. The DFP-induced loss of striatal and ileal muscarinic receptors was effectively antagonized by a concomitant administration of physostigmine (0.5 mg/kg) and atropine (5 mg/kg). Also, these drugs antagonized the DFP-induced decrease in the striatal [14C]choline uptake. Thus, the present study has demonstrated that repeated DFP administration causes a specific decrease in muscarinic receptors and [14C]choline uptake in the striatum and ileal longitudinal muscle of guinea pigs which is closely associated with a considerable (more than 50%) depression of the tissue AChE. In addition, these adaptive changes by DFP were effectively antagonized by physostigmine and atropine.

Acetylcholinesterase↗

(+-)-Methyl-2,3,3a,4-tetrahydro-1H-indolo [3,2,1-de] [1,5] naphthyridine-6-carboxylate monohydrochloride facilitates phosphatidylinositol hydrolysis: possible involvement of muscarinic and nonmuscarinic mechanisms.

The stimulation of the formation of inositol phosphate (IP) by (+-)-methyl-2,3,3a,4-tetrahydro-1H-indolo [3,2,1-de] [1,5] naphthyridine-6-carboxylate monohydrochloride (vinconate), a novel indolonaphthyridine derivative, was studied using both cerebral cortical slices and crude synaptic membranes prepared from the rat brain. Vinconate (10 mM-1 mM) inhibited the binding of [3H]quinuclidinyl benzilate to the muscarinic receptor in a dose-dependent manner and the IC50 value for [3H]quinuclidinyl benzilate binding was found to be 17 microM. The rightward shift of the inhibition curve of [3H]quinuclidinyl benzilate binding by carbachol in the presence of GTP (100 microM) was abolished by vinconate (100 microM). Carbachol (10 nM-10 mM) significantly increased [3H]IP formation in a dose-dependent manner and the rate of [3H]IP formation mediated by carbachol stimulation was significantly accentuated in the presence of 10 microM vinconate. The enhancement of [3H]IP accumulation by vinconate was inhibited by approximately 50% in the presence of atropine (1-1000 microM), although up to 1 mM of phentolamine and ketanserin had no effect on the vinconate-induced increase of phosphatidylinositol turnover. Moreover, vinconate significantly accentuated 20 mM KCl-evoked stimulation of [3H]IP formation. Vinconate had no differential effect on the ratio of IP or inositol 1,4-biphosphate and inositol 1,4,5-triphosphate formations. These results suggest that vinconate may induce a facilitation of phosphatidylinositol turnover via the stimulation of muscarinic receptors and a facilitation of coupling between muscarinic receptors and GTP-binding protein. The presence of a direct stimulatory effect of vinconate on phosphatidylinositol turnover has also been suggested.

Animals↗

Excited carbonyl formation in the combination and disproportionation of free radicals.

The pyrolyisis of di-tert-butyl peroxyoxalate in the presence of para-substituted benzaldehydes produces almost quantitatively the corresponding p,p'-disubstituted benzils. The formation of these products is accompanied by chemiluminescence arising from excited triplets. From the quantum yield of excited triplet generation and the rate constants for the triplet photocleavage it is possible to obtain the change in Gibbs free energy associated with triplet formation. The values obtained are -5.6, -5.7 and -8.1 kcal/mol for benzil, p,p'-dimethylbenzil and p,p'-dimethoxybenzil, respectively. The pyrolysis of di-tert-butyl peroxyoxalate in the presence of isopropanol or benzoin leads to the formation of acetone and benzil. These products are generated in disproportionation processes involving the alpha-hydroxy radical produced by hydrogen abstraction. The luminescence observed in these reactions constitutes the first experimental indication of excited species generation in the disproportionation of uncorrelated free radicals.

1-Propanol↗

In situ synthesis of trisubstituted methanol ligands and their potential as one-pot generators of cubane-like metal complexes.

Two different one pot routes to a variety of metal cubane compounds are reported; one route is based on an in situ benzilic acid type rearrangement and the other involves in situ nucleophilic attack at a ketone. Diketosuccinic acid in basic solution in the presence of certain divalent metal ions undergoes a benzilic acid type rearrangement to generate the carbon oxyanion, C(CO(2) (-))(3)O(-), which serves as a cubane-forming bridging ligand in a series of octanuclear complexes of composition [M(8){C(CO(2))(3)O}(4)](H(2)O)(12) (M=Mg, Mn, Fe, Co, Ni, Zn). At the heart of each of these highly symmetrical aggregates is an M(4)O(4) cubane core, each oxygen component of which is provided by the alkoxo centre of a C(CO(2) (-))(3)O(-) ligand. Reaction of 2,2'-pyridil, (2-C(5)H(4)N)COCO(2-C(5)H(4)N), and calcium nitrate in basic alcoholic solution, which proceeds by a similar benzilic acid type rearrangement, gives the cubane compounds, [Ca(4)L(4)(NO(3))(4)] in which L=(2-C(5)H(4)N)(2)C(COOR)O(-) (R=Me or Et). Nucleophilic attack by bisulfite ion at the carbonyl carbon atom of 2,2'-dipyridyl ketone in the presence of certain divalent metals generates the electrically neutral complexes, [{(C(5)H(4)N)(2)SO(3)C(OH)}(2)M] (M=Mn, Fe, Co, Ni, Zn and Cd). Cubane-like complexes [M(4){(C(5)H(4)N)(2)SO(3)C(O)}(4)] (M=Zn, Mn) can be obtained directly from 2,2'-dipyridyl ketone in one-pot reaction systems (sealed tube, 120 degrees C) if a base as weak as acetate ion is present to deprotonate the OH group of the initial [(C(5)H(4)N)(2)SO(3)C(OH)](-) bisulfite addition compound; the [(C(5)H(4)N)(2)SO(3)C(O)](2-) ligand in this case plays the same cubane-forming role as the ligands C(COO(-))(3)O(-) and (2-C(5)H(4)N)(2)C(COOR)O(-) above. When excess sodium sulfite is used in similar one-pot reaction mixtures, the monoanionic complexes, [M(3)Na{(C(5)H(4)N)(2)SO(3)C(O)}(4)](-) (M=Zn, Mn, Co) with an M(3)NaO(4) cubane core, are formed directly from 2,2'-dipyridyl ketone.

Ligands↗

Differential modulation of organophosphate-sensitive muscarinic receptors in rat brain by parathion and chlorpyrifos.

We previously reported similar levels of brain cholinesterase inhibition but marked differences in toxicity following acute maximum tolerated doses of the organophosphate pesticides parathion and chlorpyrifos. Because extensive acetylcholinesterase inhibition often induces compensatory changes in cholinergic receptor populations, we compared the effects of parathion and chlorpyrifos on brain muscarinic receptors. Adult male rats were treated with vehicle or the maximum tolerated dose of parathion (18 mg/kg, sc) or chlorpyrifos (279 mg/kg, sc) and observed for signs of acute toxicity. Similarly treated animals were sacrificed at 2, 7, or 14 days after treatment for measurement of cholinesterase activity and binding to the nonselective muscarinic antagonist [3H]quinuclidinyl benzilate, the M2-preferential antagonist [3H]AFDX-384, and the high-affinity agonist [3H]cis-methyldioxolane. More acute toxicity was noted after parathion treatment. Both insecticides caused similar levels (> 85%) of maximal cholinesterase inhibition and reductions (up to 55%) in atropine-sensitive quinuclidinyl benzilate binding (i.e., total muscarinic receptors) and [3H]AFDX-384 binding in cortex and striatum. Parathion also reduced, whereas chlorpyrifos increased, total muscarinic receptor binding and [3H]AFDX-384 binding in the cerebellum. When tissues were preincubated with paraoxon (10 microM), radiolabeling of a subset of quinuclidinyl benzilate binding sites was blocked and the apparent densities of these organophosphate-sensitive receptors in all three tissues were decreased (16% maximal) by parathion but increased (up to 37%) by chlorpyrifos. Similarly, parathion decreased whereas chlorpyrifos increased [3H]cis-methyldioxolane binding sites in all three brain regions. We propose that differential modulation of these organophosphate-sensitive muscarinic receptors contributes to differences in acute toxicity following exposure to these pesticides.

Animals↗

Stability-indicating analysis of injectable estrogen-androgen combinations in formulations containing corn oil.

A method was developed for the analysis of testosterone 17-enanthate 3-benzilic acid hydrazone, 17-beta-estradiol 3,17-dienanthate, and estradiol benzoate combinations dissolved in an oily vehicle. Testosterone 17-enanthate 3-benzilic acid hydrazone was separated from the other drugs and vehicle components by chromatography on an acetonitrile-infusorial earth column followed by quantitation using UV spectroscopy. The estradiol esters were separated from the oil by an additional chromatographic step using a heptane-silanized infusorial earth column prior to quantitation by GLC. Subjecting formulations to elevated temperatures resulted in detectable losses for testosterone 17-enanthate 3-benzilic acid hydrazone and 17-beta-estradiol 3,17-dienanthate. For both drugs, degradation was due to hydroxysis; the degradation products, testosterone 17-enanthate and 17-beta-estradiol 17-enanthate, did not interfere with the intact drug determination. Methods also were developed to estimate degradation product levels in the formulation.

Chromatography, Gas↗

Solubility in binary solvent systems I: Specific versus nonspecific interactions.

Solubilities are reported for benzil in carbon tetrachloride-alkane (isooctane, n-octane, cyclooctane) systems at 25 degrees and in similar binary mixtures containing cyclohexane plus alkane. The results of these measurements are compared to solution models previously developed for solubility in systems containing specific solute-solvent interactions and to models for purely nonspecific interactions. A stoichiometric complexation model based primarily on specific solute-solvent interactions requires several equilibrium constants to mathematically describe the experimental solubilities in binary carbon tetrachloride mixtures. However, there was no direct experimental evidence to suggest complexation between benzil and carbon tetrachloride. In comparison, expressions derived from the Nearly Ideal Binary Solvent (NIBS) model for nonspecific interactions predict experimental solubilities with a maximum deviation of 5% and an overall deviation of 1.0%. The success of the NIBS approach for this system is significant because the mole fraction solubility of benzil changes by a factor of 14 in the carbon tetrachloride-isooctane system.

Alkanes↗

Changes in gamma-aminobutyric acid, mu-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens.

Discrete quinolinic acid lesions in the nucleus accumbens altered [3H]muscimol binding to gamma-aminobutyric acid receptors, [125I]neurotensin binding to neurotensin receptors, [125I]Tyr-D-Ala-Gly-NMePHe-Gly-OH binding to mu-opioid receptors, and [3H]quinuclidinyl benzilate binding to muscarinic receptors. Within lesions of the lateral accumbens core, [3H]muscimol binding increased and [125I]Tyr-D-Ala-Gly-NMePhe-Gly-OH, [125I]neurotensin and [3H]quinuclidinyl benzilate binding decreased. Lesions of the medial nucleus accumbens resulted in decreased [125I]Tyr-D-Ala-Gly-NMePhe-Gly-OH and [3H]quinuclidinyl benzilate binding while no alterations were observed for [3H]muscimol or [125I]neurotensin binding. These data support anatomical distinctions between medial and lateral nucleus accumbens. Destruction of intrinsic neurons in the dorsomedial nucleus accumbens core increased [3H]muscimol binding in the dorsal rim of the ventral pallidum and the rostral globus pallidus without altering [125I]Tyr-D-Ala-Gly-NMePhe-Gly-OH binding. Destruction of neurons in the lateral nucleus accumbens core or medial shell did not alter [3H]muscimol binding in the ventral pallidum. The lack of upregulation in gamma-aminobutyric acid receptors suggests that the gamma-aminobutyric acid-containing projection from the dorsomedial core to the dorsal rim of the ventral pallidum differs from the projection from the lateral accumbens core and medial shell to the more ventral regions of the pallidum. Fluoro-gold retrograde tracer histochemistry confirmed the specific projection from the dorsomedial core to the dorsal ventral pallidum; and from the shell of the nucleus accumbens to more ventral regions of the ventral pallidum.

Animals↗

Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain.

The distribution of M1 and M2 muscarine receptors in the rat brain was investigated by in vitro autoradiography. Muscarine receptors were visualized after complete receptor uncoupling in ethylenediaminetetraacetic acid buffer containing 1 mM N-ethyl maleimide and saturation with the ligand [3H]quinuclidinyl benzilate. Pirenzepine, an M1-selective antagonist, was used in our assays as a counter ligand to occlude M1 sites, allowing the primary ligand, [3H]quinuclidinyl benzilate, to label the remaining M2 muscarine receptors. In adjacent section, M1 muscarine receptors were labelled with [3H]quinuclidinyl benzilate in the presence of sufficient carbachol, and M2-selective agonist, to inhibit the binding to M2 sites. Our results reveal a heterogeneous distribution of M1 and M2 receptors. Increased densities of carbachol-resistant and pirenzepine-sensitive sites (M1 receptor subtype) were apparent over many forebrain structures including the olfactory tubercle, caudate-putamen, nucleus accumbens, hippocampus, amygdala and cerebral cortex. In contrast, pirenzepine-resistant and carbachol-sensitive sites (M2 receptor subtype) were distributed throughout the brain with increased densities apparent over regions known to contain large numbers of cholinergic cell bodies. M2 receptor localization patterns were largely coincident with the regional distribution and intensity of acetylcholinesterase positive sites. Since the M2 receptor pattern appears to parallel regional innervation densities, we conclude that the M2 receptor may serve as a marker for cholinergic pathways. The findings also suggest that M1 muscarine receptors are involved in the presumptive postsynaptic actions of acetylcholine in many forebrain structures.

Acetylcholine↗

Reduction of diesters of 1,2-diols. Regioselective C-O bond cleavage of the anionic forms.

The electrochemical reduction of benzoate diesters of glycols has been studied in acetonitrile and N,N-dimethylformamide as solvents. The reductions occur in two closely spaced one-electron steps, and it was found that the dianion diradicals decompose by one of two routes, depending on the substituents on the ethylene moiety: cleavage of two benzoates to produce alkene or formation of benzil by way of a postulated cyclic intermediate to produce also the dianion of the diol. These correspond to cleavage of the R-OC(O)Ar bonds and the RO-C(O)Ar bonds, respectively. When the radical formed by the former cleavage is a primary or secondary radical, the reaction is too slow to compete with the latter reaction that produces benzil. However, when that radical is either tertiary or benzylic, the former cleavage reaction is fast and no benzil is detected. The dianions of p-cyano- and p-nitrobenzoate esters are rather stable on the voltammetric time scale. However, the addition of lithium ions results in detectable formation of 4,4'-dicyanobenzil from four different p-cyanobenzoate diesters.

Journal Article↗

Muscarinic cholinergic receptors in murine lymphocytes: demonstration by direct binding.

Using [3H]quinuclidinyl benzilate as a specific cholinergic muscarinic ligand, it has been demonstrated that lymphocytes have muscarinic binding sites. There are approximately 200 sites per cell and the dissociation constant for quinuclidinyl benzilate is approximately 1 X 10(-9) M. Quinuclidinyl benzilate receptor binding is blocked by atropine and oxotremorine.

Animals↗